Management of Relapsed and Refractory Hodgkin Lymphoma in 2018

被引：2

作者：

Rutherford, Sarah C. ^{[1
]}

Leonard, John P. ^{[1
]}

机构：

[1] Weill Cornell Med, New York Presbyterian Hosp, Weill Dept Med, Meyer Canc Ctr,Div Hematol & Med Oncol, 1305 York Ave,7th Floor, New York, NY 10021 USA

来源：

JAMA ONCOLOGY | 2018年 / 4卷 / 08期

关键词：

STEM-CELL TRANSPLANTATION; BRENTUXIMAB VEDOTIN; PHASE-II; NIVOLUMAB; TRIAL; MULTICOHORT; THERAPY; FAILURE;

D O I：

10.1001/jamaoncol.2018.1767

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1120 / 1121

页数：2

共 10 条

[1] PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma [J].

Ansell, Stephen M. ;

Lesokhin, Alexander M. ;

Borrello, Ivan ;

Halwani, Ahmad ;

Scott, Emma C. ;

Gutierrez, Martin ;

Schuster, Stephen J. ;

Millenson, Michael M. ;

Cattry, Deepika ;

Freeman, Gordon J. ;

Rodig, Scott J. ;

Chapuy, Bjoern ;

Ligon, Azra H. ;

Zhu, Lili ;

Grosso, Joseph F. ;

Kim, Su Young ;

Timmerman, John M. ;

Shipp, Margaret A. ;

Armand, Philippe .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (04) :311-319

[2] Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial [J].

Armand, Philippe ;

Engert, Andreas ;

Younes, Anas ;

Fanale, Michelle ;

Santoro, Armando ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Collins, Graham P. ;

Ramchandren, Radhakrishnan ;

Cohen, Jonathon B. ;

De Boer, Jan Paul ;

Kuruvilla, John ;

Savage, Kerry J. ;

Trneny, Marek ;

Shipp, Margaret A. ;

Kato, Kazunobu ;

Sumbul, Anne ;

Farsaci, Benedetto ;

Ansell, Stephen M. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (14) :1428-+

[3] Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma [J].

Chen, Robert ;

Zinzani, Pier Luigi ;

Fanale, Michelle A. ;

Armand, Philippe ;

Johnson, Nathalie A. ;

Brice, Pauline ;

Radford, John ;

Ribrag, Vincent ;

Molin, Daniel ;

Vassilakopoulos, Theodoros P. ;

Tomita, Akihiro ;

von Tresckow, Bastian ;

Shipp, Margaret A. ;

Zhang, Yinghua ;

Ricart, Alejandro D. ;

Balakumaran, Arun ;

Moskowitz, Craig H. .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) :2125-+

[4] Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma [J].

Herrera, Alex F. ;

Moskowitz, Alison J. ;

Bartlett, Nancy L. ;

Vose, Julie M. ;

Ramchandren, Radhakrishnan ;

Feldman, Tatyana A. ;

LaCasce, Ann S. ;

Ansell, Stephen M. ;

Moskowitz, Craig H. ;

Fenton, Keenan ;

Ogden, Carol Anne ;

Taft, David ;

Zhang, Qu ;

Kato, Kazunobu ;

Campbell, Mary ;

Advani, Ranjana H. .

BLOOD, 2018, 131 (11) :1183-1194

[5] Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma [J].

Johnson, Peter ;

Federico, Massimo ;

Kirkwood, Amy ;

Fossa, Alexander ;

Berkahn, Leanne ;

Carella, Angelo ;

d'Amore, Francesco ;

Enblad, Gunilla ;

Franceschetto, Antonella ;

Fulham, Michael ;

Luminari, Stefano ;

O'Doherty, Michael ;

Patrick, Pip ;

Roberts, Thomas ;

Sidra, Gamal ;

Stevens, Lindsey ;

Smith, Paul ;

Trotman, Judith ;

Viney, Zaid ;

Radford, John ;

Barrington, Sally .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (25) :2419-2429

[6] PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study [J].

Moskowitz, Alison J. ;

Schoeder, Heiko ;

Yahalom, Joachim ;

McCall, Susan J. ;

Fox, Stephanie Y. ;

Gerecitano, John ;

Grewal, Ravinder ;

Hamlin, Paul A. ;

Horwitz, Steven ;

Kobos, Rachel ;

Kumar, Anita ;

Matasar, Matthew ;

Noy, Ariela ;

Palomba, M. Lia ;

Perales, Miguel-Angel ;

Portlock, Carol S. ;

Sauter, Craig ;

Shukla, Neerav ;

Steinherz, Peter ;

Straus, David ;

Trippett, Tanya ;

Younes, Anas ;

Zelenetz, Andrew ;

Moskowitz, Craig H. .

LANCET ONCOLOGY, 2015, 16 (03) :284-292

[7] Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Moskowitz, Craig H. ;

Nademanee, Auayporn ;

Masszi, Tamas ;

Agura, Edward ;

Holowiecki, Jerzy ;

Abidi, Muneer H. ;

Chen, Andy I. ;

Stiff, Patrick ;

Gianni, Alessandro M. ;

Carella, Angelo ;

Osmanov, Dzhelil ;

Bachanova, Veronika ;

Sweetenham, John ;

Sureda, Anna ;

Huebner, Dirk ;

Sievers, Eric L. ;

Chi, Andy ;

Larsen, Emily K. ;

Hunder, Naomi N. ;

Walewski, Jan .

LANCET, 2015, 385 (9980) :1853-1862

[8]

Rossi C, 2017, 50 AM SOC HEM ANN M

[9] Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial [J].

Younes, Anas ;

Santoro, Armando ;

Shipp, Margaret ;

Zinzani, Pier Luigi ;

Timmerman, John M. ;

Ansell, Stephen ;

Armand, Philippe ;

Fanale, Michelle ;

Ratanatharathorn, Voravit ;

Kuruvilla, John ;

Cohen, Jonathon B. ;

Collins, Graham ;

Savage, Kerry J. ;

Trneny, Marek ;

Kato, Kazunobu ;

Farsaci, Benedetto ;

Parker, Susan M. ;

Rodig, Scott ;

Roemer, Margaretha G. M. ;

Ligon, Azra H. ;

Engert, Andreas .

LANCET ONCOLOGY, 2016, 17 (09) :1283-1294

[10] Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma [J].

Younes, Anas ;

Gopal, Ajay K. ;

Smith, Scott E. ;

Ansell, Stephen M. ;

Rosenblatt, Joseph D. ;

Savage, Kerry J. ;

Ramchandren, Radhakrishnan ;

Bartlett, Nancy L. ;

Cheson, Bruce D. ;

de Vos, Sven ;

Forero-Torres, Andres ;

Moskowitz, Craig H. ;

Connors, Joseph M. ;

Engert, Andreas ;

Larsen, Emily K. ;

Kennedy, Dana A. ;

Sievers, Eric L. ;

Chen, Robert .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (18) :2183-2189

← 1 →